| The following table summarizes the convertible notes, performance rights, listed options and unlisted options that were not included in the calculation of weighted average number of ordinary shares because they are anti-dilutive for the periods presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Consolidated |
|
| |
June 30, 2026
Number |
|
|
June 30, 2025
Number |
|
|
June 30, 2024
Number |
|
| Unlisted options* |
|
|
— |
|
|
|
847,600 |
|
|
|
847,600 |
|
| Convertible notes |
|
|
— |
|
|
|
7,432,958 |
|
|
|
7,261,072 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-executive director performance rights |
|
|
4,695,065 |
|
|
|
1,211,112 |
|
|
|
2,161,392 |
|
| Performance rights |
|
|
11,994,156 |
|
|
|
16,237,064 |
|
|
|
13,870,535 |
|
| * |
This is related to warrant associated with convertible notes, please refer to note 19 for more details. |
|